In short. Sun protection and not smoking, the strongest evidence in the whole field, and very little else. Neither needs a clinical treatment.

Key points

  • Neither of the two requires a prescription, a device or a course of treatment, and neither generates a commercial relationship.
  • That is not a reason to discount them; it is the reason the category marketed as prejuvenation is built around things that do.

The evidential part of this subject is short and it does not involve a clinic. Two measures carry substantial support, one clinical claim carries a limited one, and the rest of the category carries none.

Sun protection, first and by a distance

The strongest preventive evidence in the whole field belongs to sun protection. It comes from long-running population studies rather than short trials in small groups, the mechanism is direct because reducing ultraviolet exposure reduces the accumulation of photodamage, and the benefit applies to everyone rather than to a subgroup. It also requires no clinical intervention, which means the risks are close to zero and the cost is trivial. Its weakness is behavioural: the benefit depends on daily use and most people use less than they think.

Not smoking

Second, and equally free of clinical involvement. Smoking is associated with earlier and more pronounced facial ageing consistently across studies and populations, and that part of the process is preventable by not smoking. It is a statement about a population rather than a prediction about an individual, and taken with sun protection it accounts for the great majority of what can honestly be described as prevention here.

The measures with evidence are not products

Neither of the two requires a prescription, a device or a course of treatment, and neither generates a commercial relationship. That is not a reason to discount them; it is the reason the category marketed as prejuvenation is built around things that do.

The one limited clinical claim

Where a movement line is already visible and is produced by muscle activity, treating it reduces the movement that deepens it, and the line does not progress as it otherwise would while the treatment continues. That is preventing a change from worsening, and it is a real claim about a finding that exists. It is graded as limited because it is narrower than the prevention claim usually made from it, and because it applies to a line that is already there rather than to a change that has not happened.

Everything else

Early injectables for volume, early devices for collagen, and maintenance programmes have no demonstrated preventive effect. The reasoning behind them is a mechanism, and a mechanism is a reason to study something rather than a result. Where a claim moves from what a treatment does to what it will prevent, it has left the evidence behind, and that applies across this whole category rather than to any single product.

The evidence, in order

  • Established: daily sun protection, and not smoking. Neither needs clinical treatment.
  • Limited: treating a visible movement line limits how much it deepens.
  • Not supported: that any clinical treatment prevents a change from appearing.

Everything marketed under this name sits below the third line, and the first line is where the evidence actually is.

Related reading

Frequently asked questions

What has the strongest evidence for preventing skin ageing?

Daily sun protection, by a wide margin. It is supported by long-running studies in whole populations, the mechanism is direct, and it requires no clinical intervention. Not smoking is second, and is also supported by consistent population evidence. Taken together they account for the great majority of what can honestly be called prevention in this subject.

Is anything clinical supported for prevention?

Only in a limited sense. Treating a visible movement line limits how much it deepens, which is preventing a change from worsening rather than preventing it from appearing. That is graded as limited and it applies to a line that exists. Nothing clinical has been shown to prevent a change from appearing where none was present.

Why are the best-supported measures not sold as prejuvenation?

Because they are not products. Sun protection and not smoking cost little, are not prescribed, and generate no commercial relationship. A category built around them would have nothing to sell, which is why the term prejuvenation is applied to treatments that carry risk rather than to the measures with the evidence.

Risks & Limitations

  • A face with no findings has no measurable baseline, so a preventive benefit cannot be demonstrated while the risks of treatment remain real.
  • Nothing is approved with a preventive indication for facial ageing; approvals are for treating a change that is already present.
  • Sun protection and not smoking are the only preventive measures with substantial support, and neither needs a clinical treatment.
  • Treating early or maintaining a result is not prevention, and repeated treatment accumulates the labelled risks.
  • A claim that nothing could contradict is a claim that cannot be supported either, and this category's claims are of that kind.

When to Seek Care

  • A mole or patch that is changing in size, shape or colour — have it assessed by a clinician.
  • A lesion that bleeds, itches or will not heal — have it assessed by a clinician.
  • Blistering, crusting or pigment change that follows a device treatment — have it assessed by a clinician.
  • Severe pain, dusky or mottled skin, or a change in vision after an injection — seek emergency care immediately.

References & Further Reading

  • World Health Organization (WHO) — ultraviolet radiation and skin cancer prevention guidance
  • U.S. Food and Drug Administration (FDA) — approved products and devices and their labelled indications
  • National Medical Products Administration (NMPA, China) — approved products and their indications
  • Cochrane Library — systematic reviews of photoprotection and topical treatments
  • Chinese Medical Association Dermatology Branch — clinical guidance

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is a review of published evidence and regulation, not medical advice, and it does not cite individual studies. It is not a booking page and it does not recommend a treatment, for or against. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.